The results have been published in The New England Journal of Medicine in an article with the participation of Dr. Antonio Álvarez, researcher of the Pneumology group.

Today, 30 November, the main research lines in which both institutions will be working together are revealed.

Vall d'Hebron and the Barcelona PID Foundation are back with Bufa la Bombolla campaign

The nurse received this recognition thanks to HEPARJOC-ACTUA, an educational tool to improve the diagnosis of Hepatitis B.

The nurses Rosa Casado, Eva Gavilan and Miguel Ángel Robles from Vall Hebron Research have been three of the winners of the call for grants of the Col-legi this 2021

The professionals and patients of Vall d’Hebron painted their hands for a mural for 25N, the international day against gender-based violence.

Vall d’Hebron hosted the 14th International NOTES-WIDER-Barcelona course on 22 and 23 November, which welcomed a hundred international professionals in Surgery, Clinical endoscopy and Gastroenterology.

Dr. José García Arumi and Dr. Anna Duarri from the Ophthalmology research group at Vall Hebron Recerca lead the project. 

In addition to COVID-19, new vaccines have been presented to combat flu, the herpes-zoster virus, meningococcus and pneumococcus.

The Ministry of Science and Innovation granted more than €1.4 million to the project "Early molecular nanoDIAGnostics of Brain tumours using ImmunePET (DIAGBI)" with the participation of Vall d’Hebron through the Molecular Medicine Imaging Group.

An analysis of thrombi would allow the cause of a stroke to be detected and therefore permit the selection of an appropriate treatment to prevent a stroke and to carry out a more thorough follow-up.

All the activities associated with virtual and augmented reality, robotics, simulation, 3D, entrepreneurship and research came to an end after five days.

Biopsies obtained by flexible bronchoscopy have been used to analyze which patients have sequelae in the lung in order to recommend, if necessary, the administration of corticosteroids as a treatment.

The EVOLUTION trial is currently in phase IIb and it will evaluate the effect of the Vafidemstat drug on cognitive effects and the negative effects deriving from the illness.

Among the 108 Spanish scientists recognised on the 2021 Web of Science Group list, two from Vall d’Hebron Research Institute stand out: Dr Maria Buti and Dr Xavier Montalban.

The team led by Dr. Matilde E. LLeonart has observed the presence of elevated levels of syntenin-1 in chemotherapy-resistant cells and cancer stem cells.

La Setmana de la Innovació i la Ciència a Vall d’Hebron seran cinc dies plens d’activitats relacionades amb la realitat virtual i augmentada, la robòtica, la simulació, el 3D, l’emprenedoria o la recerca.

The AECC Research Grants for 2021 will drive the research headed by Dr Fernanda da Silva and Dr Eva Colás.

Within the framework of the project “Cooperative Cohort COVID-19”, a mobile application will allow citizens to transfer their data under certain conditions and thus actively collaborate in research projects.

The jury unanimously recognised her efforts in the fight against COVID-19 and the cooperation with the care sector for dependent elderly people.

The grant will allow to carry out a validation study of a digital tool for monitoring patients with advanced diabetic kidney disease.

The analysis aimed to identify trends in indicators of quality of care in the surgical treatment of adult scoliosis, such as complications, reinterventions and impact on the quality of life of patients with spinal deviation.

Dr Albert Salazar, director of Vall d’Hebron and Chairman of the EUHA highlighted “the significance of this alliance, which allows us to establish synergies with Europe and thus improve patient care”.

Vall d’Hebron is looking for volunteers over the age of 18 who have received the Pfizer-BioNTech Comirnaty vaccine against COVID-19 at least 6 months ago.